Abstract Review Complete!
Notification Letters to authors will be emailed in the next few days. Sessions Chairs will also receive invitation letters soon.
Late-Breaking Abstracts Still Being Accepted!
Click here to submit your abstract.
Submission Deadline: 15 September 2011 (Midnight, US Central Time)
Late-Breaking Abstract Submission Guidelines
Late-Breaking Abstracts MUST be of high quality, represent an important research advancement and present information that was not available at the time of regular abstract submission.
- These abstracts must present information that is significant to clinical, translational or basic science, novel, uses appropriate study design, analytical methods and statistical methods and is clearly and logically written.
- Submitters will be required to explain why their abstract is important or late breaking.
- Abstracts submitted only because they missed the initial deadline for regular abstracts will not be considered.
- Late Breaking Abstracts are competitively reviewed.
- The abstract must be written and presented in English.
- Abstracts must contain original data and meet international ethical standards.
- A maximum of three abstracts may be submitted by the same Presenting Author.
- An abstract cannot be submitted to more than one thematic category.
- Case reports that include findings that are significant and have applied appropriate statistical and analytical methods will be considered for presentation. All other case reports will not be accepted for oral or poster presentation.
- Previously published and presented abstracts can be submitted.
- Use a maximum of 350 words for the abstract text
- The Abstract Title must have the first letter of each word capitalized.
- Tables and graphs should not be included in the abstract.
- References (maximum of 2) can be included in the body of the text.
- The abstract title and the author(s) or names of institutions are not to be included in the abstract text.
- Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time the full wording appears in the body of the text.
- Non-proprietary (generic) names of drugs, written in lower case, are required at the first mention of a drug.
- Trade names are not allowed.
Organization of the Late-Breaking Abstract
In order to make the abstract as informative as possible, please provide:
- a brief statement of the purpose of the study
- the method used
- the result observed
- the conclusions based upon the results
It is inadequate to state: "The results will be discussed." or "The data will be presented."
We kindly ask you to subtitle the paragraphs in bold format in the following order: Background, Methods, Results, and Conclusions.
A) Background: A statement of purpose of the study (preferably one sentence).
B) Methods: A brief statement of the methods used. For abstracts reporting clinical research, a sentence or phrase presenting the most important selection criteria for subjects should be included.
C) Results: A summary of the results presented in sufficient detail with statistical analysis to support the conclusions.
D) Conclusions: A statement of the conclusions reached. It is not satisfactory to state, "the results will be discussed," or "other data will be presented," etc.
Late-Breaking Abstract Revisions
Changes to abstracts are accepted only until the submission deadline by using the abstract submission website. After 15 September, no changes or revisions will be allowed.
Late-Breaking Abstract Submission Disclosure Policy
WAO requires that Presenting Authors submit all Conflict of Interest Disclosures for CME compliance purposes. CME is provided by the European Accreditation Council for Continuing Medical Education.
Notification of Acceptance
Notification of acceptance/rejection will be emailed by the middle of October 2011. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time.
Registration and Payment
The Presenting Author of the Late-Breaking Abstract must register for the Congress and pay the fee before 15 October 2011. Abstracts will be automatically withdrawn if the Presenting Author is not registered.
Abstract presenters are responsible for arranging and paying for their own registration, travel and hotel arrangements. Affordable accommodation options are available at: http://www.worldallergy.org/wac2011/accommodation/.
Attendance of Presenters
WAO cannot guarantee that those Presenting Authors who do not show up during the session will be accepted for abstract presentations at future meetings.
Regular Abstract Submission for the XXII World Allergy Congress is now closed.
For questions, please contact firstname.lastname@example.org.
Authors who submitted abstracts will be notified by 15 September 2011.
Those authors whose abstracts are accepted will have the opportunity to present them in Oral Abstract Sessions or thematic Poster Sessions on 5, 6 and 7 December 2011. In the Oral Abstract Sessions, the authors will be able to explain and respond to questions from multinational delegates. The Poster Sessions will be displayed in a prominent location and accessible to all to review during lunch and coffee breaks.
All authors submitting abstracts may participate toward enhanced visibility through two WAC Abstract Submission Contests. These contests provide an opportunity to be part of the global reach of WAO to allergists/immunologists through the WAO Journal and the education features of the WAO website.
All abstracts submitted on case reports will be considered for selection by the Abstract Review Committee as potential WAO Interactive Case Reports, which are published online and can be cited on CVs. (For examples, see http://www.worldallergy.org/interactive_case_reviews/). The winning authors will be showcased as WAO Featured Abstract Authors during the Congress.
All abstract authors, in addition, may elect to submit a paper to the WAO Journal based on their presentation. If the paper is chosen for publication by 1 October 2011, the author will be showcased as a WAO Journal Featured Abstract Author.
All featured authors from both contests will be identified as winners on their posters or oral abstract presentations and in the WAC 2011 Final Program.
Abstracts submitted for presentation at the 2011 World Allergy Congress will be reviewed by experts in the field: members of the WAO Board of Directors, WAC 2011 Scientific Program Committee, WAO Journal Editorial Board and the WAO Councils & Committees.
|Cezmi Akdis (Switzerland)
Mubeccel Akdis (Switzerland)
Ignacio J. Ansotegui (Spain)
Jeanette Arnold (United States)
Claus Bachert (Belgium)
Carlos E. Baena-Cagnani (Argentina)
Mark Ballow (United States)
Michael S. Blaiss (United States)
Sergio Bonini (Italy)
G. Walter Canonica (Italy)
Thomas B. Casale (United States)
Luis Caraballo (Colombia)
Gennaro D'Amato (Italy)
Sergio Del Giacco (Italy)
Pascal Demoly (France)
Lawrence DuBuske (United States)
Motohiro Ebisawa (Japan)
Yehia El-Gamal (Egypt)
Alessandro Fiocchi (Italy)
Amiran Gamkrelidze (Georgia)
Maureen George (United States)
Roy Gerth van Wijk (Netherlands)
Sandra González-Díaz (Mexico)
Tari Haahtela (Finland)
Stephen T. Holgate (United Kingdom)
Elham Hossny (Egypt)
Richard F. Lockey (United States)
Jose Huerta Lopez (Mexico)
Juan Carlos Ivancevich (Argentina)
Omer Kalayci (Turkey)
Michael A. Kaliner (United States)
Connie Katelaris (Australia)
|Phillip E. Korenblat (United States)
Marek L. Kowalski (Poland)
Dennis Ledford (United States)
Bee-Wah Lee (Singapore)
Francesca Levi-Schaffer (Israel)
Shyam Mohapatra (United States)
Hee-Bom Moon (Korea)
Mario Morais de Almeida (Portugal)
Takemasa Nakagawa (Japan)
Hugo E. Neffen (Argentina)
Hae-Sim Park (Korea)
Giovanni Passalacqua (Italy)
Ruby Pawankar (Japan)
Todor Popov (Bulgaria)
Jay Portnoy (United States)
Paul Potter (South Africa)
Johannes Ring (Germany)
Noel Rodriguez-Perez (Mexico)
Nelson Rosario (Brazil)
Lanny Rosenwasser (United States)
Hirohisa Saito (Japan)
Hugh Sampson (United States)
Mario Sanchez-Borges (Venezuela)
Joaquin Sastre Dominguez (Spain)
Holger Schunemann (Canada)
Revaz I. Sepiashvili (Russia)
Tatiana Slavyanskaya (Russia)
Paolo Tassinari (Venezuela)
Pakit Vichyanond (Thailand)
Vk Vijayan (India)
Dana Wallace (United States)
Ronald van Ree (Netherlands)
Last updated: September 6, 2011